Pathophysiology and treatment of obesity-related hypertension

被引:38
|
作者
Chrysant, Steven G. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, 5700 Mistletoe Court, Oklahoma City, OK 73142 USA
来源
JOURNAL OF CLINICAL HYPERTENSION | 2019年 / 21卷 / 05期
关键词
hypertension; mechanisms; obesity; treatment; NATRIURETIC PEPTIDES; KIDNEY-DISEASE; LEPTIN LEVEL; FAT; MECHANISMS; PRESSURE; SYSTEM; RISK; ALDOSTERONE; EXPRESSION;
D O I
10.1111/jch.13518
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The prevalence of overweight and obesity has increased significantly in the United States and worldwide. Among the many complications of obesity, hypertension is the most common and major one accounting for about 70% in the obese subjects. However, the pathophysiologic factors of obesity-related hypertension and its therapeutic options are not well understood at present. To better understand the pathophysiology of obesity-related hypertension and its treatment options, a Medline search of the English language literature was contacted between 2010 and 2018 and 22 pertinent papers were selected. The information from these papers together with collateral literature will be discussed in this review.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 50 条
  • [21] Treatments for Obesity-Related Hypertension
    Masuo, Kazuko
    CURRENT HYPERTENSION REVIEWS, 2011, 7 (03) : 184 - 199
  • [22] Optimal treatment of obesity-related hypertension - The Hypertension-Obesity-Sibutramine (HOS) Study
    Scholze, Juergen
    Grimm, Elmar
    Herrmann, Dana
    Unger, Thomas
    Kintscher, Ulrich
    CIRCULATION, 2007, 115 (15) : 1991 - 1998
  • [23] Pathophysiology of obesity-related infertility and its prevention and treatment by potential phytotherapeutics
    Uddandrao, V. V. Sathibabu
    Brahma Naidu, Parim
    Chandrasekaran, P.
    Saravanan, G.
    INTERNATIONAL JOURNAL OF OBESITY, 2024, 48 (02) : 147 - 165
  • [24] Pathophysiology of obesity-related infertility and its prevention and treatment by potential phytotherapeutics
    V. V. Sathibabu Uddandrao
    Parim Brahma Naidu
    P. Chandrasekaran
    G. Saravanan
    International Journal of Obesity, 2024, 48 : 147 - 165
  • [25] Choice of drug treatment for obesity-related hypertension: where is the evidence?
    Sharma, AM
    Pischon, T
    Engeli, S
    Scholze, J
    JOURNAL OF HYPERTENSION, 2001, 19 (04) : 667 - 674
  • [26] Identifying treatment response to antihypertensives in patients with obesity-related hypertension
    Schrover I.M.
    Dorresteijn J.A.N.
    Smits J.E.
    Danser A.H.J.
    Visseren F.L.J.
    Spiering W.
    Clinical Hypertension, 23 (1)
  • [27] Obesity-Related Hypertension? Weighing the Evidence
    Kotchen, Theodore A.
    HYPERTENSION, 2008, 52 (05) : 801 - 802
  • [28] Treating obesity-related hypertension with surgery
    Livingston, E
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (04) : 443 - 445
  • [29] Effects of hydralazine in obesity-related hypertension
    Carroll, JF
    King, JW
    Cohen, JS
    FASEB JOURNAL, 2003, 17 (05): : A1236 - A1236
  • [30] Neural mechanisms in obesity-related hypertension
    Dampney, RAL
    EXPERIMENTAL PHYSIOLOGY, 2005, 90 (05) : 671 - 671